Alcresta Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Alcresta Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3009596666
FEI Number3009596666
NameAlcresta Therapeutics, Inc.
Owner & OperatorAlcresta Therapeutics, Inc.
Contact AddressOne Newton Executive Park Suite 100
Newton MA 02462 US
Official Correspondent
  • Aparajit Panda
  • x-617-7149946-x
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration AddressOne Newton Executive Park Suite 100
Newton, MA 02462 US
Establishment TypeComplaint File Establishment per 21 CFR 820.198

FDA Filings

Device
Company
DeviceDate
Alcresta Therapeutics, Inc.
 RELiZORB 2024-05-16
Alcresta Therapeutics, Inc.
RELiZORB2019-12-04
Alcresta Therapeutics, Inc.
Relizorb2017-07-12
Alcresta Therapeutics, Inc.
Relizorb2016-06-30
Alcresta Therapeutics, Inc.
RELIZORB2015-12-16

Related Finance Registrations
NCAGE Code8CW10ALCRESTA THERAPEUTICS, INC.
CAGE Code8CW10ALCRESTA THERAPEUTICS, INC.
S.A.M. Registration8CW10 [78683247]ALCRESTA THERAPEUTICS, INC.
SEC0001673510Alcresta Therapeutics, Inc. of DELAWARE
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.